Ixosin (4-23)
General Information
DCTPep ID DCTPep02859
Peptide Name Ixosin (4-23)
Sequence KVMREVLGYERNSYKKFFLR
Sequence Length 20
UniProt ID Q2LKX9
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Cancer therapy related peptides
Activity Information
Cell Line | Disease | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|
HeLa | Human papillomavirus-related endocervical adenocarcinoma | 19% Killing=128 µM | MTT assay | 24 h | 1 |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity HEK-293: Not active up to 128 µM
Target Not available
Affinity Not available
Mechanism Not available
Structure Information
PDB ID Not available
Predicted Structure DCTPep02859
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C118H187N33O29S1
Absent amino acids ACDHIPQTW
Theoretical pI 10.16
Acidic residues 2
Basic residues 6
Polar residues 5
Molecular weight (Average) 2564.05
Molecular weight (Monoisotopic) 2562.39
Common amino acids KR
Net charge 4
Instability index (II) 9.27
Aliphatic index 68.00
Grand average of hydropathicity (GRAVY) -0.800
Half Life
1.3 hours (mammalian reticulocytes, in vitro).
3 min (yeast, in vivo).
3 min (Escherichia coli, in vivo).
Extinction coefficients
Ext. coefficient 2980
Abs 0.1% (=1 g/l) 1.162
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 27622949
Title Central Role of the Copper-Binding Motif in the Complex Mechanism of Action of Ixosin: Enhancing Oxidative Damage and Promoting Synergy with Ixosin B
Doi 10.1021/acsinfecdis.5b00140
Year 2016
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPR_17326